Lobbying Spend
—
Filings
18
Firms Hired
1
Active Period
2016–2020
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Food Allergy Safety, Treatment, Education, and Research Act of 2020
2020 · second_quarter · Firm: MEHLMAN CONSULTING, INC.
Issues related to food allergies and anaphylaxis. Labeling of allergens. HR 2117, The Food Allergy Safety Treatment, Education and Research Act. S. 3451, Food Allergy Safety, Treatment, Education, and Research (FASTER) Act. H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act - Public Law No: 116-136
Client expense: — · Firm income: $10,000
Matched citations: HR 2117
Issues related to food allergies and anaphylaxis. Labeling of allergens. HR 2117, The Food Allergy Safety Treatment, Education and Research Act. S. 3451, Food Allergy Safety, Treatment, Education, and Research (FASTER) Act. H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act - Public Law No: 116-136
Client expense: — · Firm income: $10,000
Matched citations: H.R. 748
Issues related to food allergies and anaphylaxis. Labeling of allergens. HR 2117, The Food Allergy Safety Treatment, Education and Research Act. S. 3451, Food Allergy Safety, Treatment, Education, and Research (FASTER) Act. H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act - Public Law No: 116-136
Client expense: — · Firm income: $10,000
Matched citations: S. 3451
Food Allergy Safety, Treatment, Education, and Research Act of 2020
2020 · first_quarter · Firm: MEHLMAN CONSULTING, INC.
Issues related to food allergies and anaphylaxis. Labeling of allergens. HR 2117, The Food Allergy Safety Treatment, Education and Research Act. S. 3451, Food Allergy Safety, Treatment, Education, and Research (FASTER) Act. H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act - Public Law No: 116-136
Client expense: — · Firm income: $30,000
Matched citations: HR 2117
Issues related to food allergies and anaphylaxis. Labeling of allergens. HR 2117, The Food Allergy Safety Treatment, Education and Research Act. S. 3451, Food Allergy Safety, Treatment, Education, and Research (FASTER) Act. H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act - Public Law No: 116-136
Client expense: — · Firm income: $30,000
Matched citations: H.R. 748
Issues related to food allergies and anaphylaxis. Labeling of allergens. HR 2117, The Food Allergy Safety Treatment, Education and Research Act. S. 3451, Food Allergy Safety, Treatment, Education, and Research (FASTER) Act. H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act - Public Law No: 116-136
Client expense: — · Firm income: $30,000
Matched citations: S. 3451
Food Allergy Safety, Treatment, Education, and Research Act of 2020
2019 · fourth_quarter · Firm: MEHLMAN CONSULTING, INC.
Issues related to food allergies and anaphylaxis. Labeling of allergens. HR 2117, The Food Allergy Safety Treatment, Education and Research Act.
Client expense: — · Firm income: $30,000
Matched citations: HR 2117
Food Allergy Safety, Treatment, Education, and Research Act of 2020
2019 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
Issues related to food allergies and anaphylaxis. Labeling of allergens. HR 2117, The Food Allergy Safety Treatment, Education and Research Act.
Client expense: — · Firm income: $30,000
Matched citations: HR 2117
Food Allergy Safety, Treatment, Education, and Research Act of 2020
2019 · second_quarter · Firm: MEHLMAN CONSULTING, INC.
Issues related to food allergies and anaphylaxis. Labeling of allergens. HR 2117, The Food Allergy Safety Treatment, Education and Research Act.
Client expense: — · Firm income: $30,000
Matched citations: HR 2117
FDA Reauthorization Act of 2017
2018 · first_quarter · Firm: MEHLMAN CONSULTING, INC.
Issues related to food allergies and anaphylaxis. H.R. 2430 and S. 934 - FDA User Fee Reauthorization Act. Labeling of allergens. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2430
FDA Reauthorization Act of 2017
2018 · first_quarter · Firm: MEHLMAN CONSULTING, INC.
Issues related to drug pricing. H.R. 2430 and S. 934 - FDA User Fee Reauthorization Act. Labeling of allergens. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2430
FDA Reauthorization Act of 2017
2018 · first_quarter · Firm: MEHLMAN CONSULTING, INC.
Issues related to drug pricing. H.R. 2430 and S. 934 - FDA User Fee Reauthorization Act. Labeling of allergens. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations.
Client expense: — · Firm income: $20,000
Matched citations: S. 934
FDA Reauthorization Act of 2017
2018 · first_quarter · Firm: MEHLMAN CONSULTING, INC.
Issues related to food allergies and anaphylaxis. H.R. 2430 and S. 934 - FDA User Fee Reauthorization Act. Labeling of allergens. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations.
Client expense: — · Firm income: $20,000
Matched citations: S. 934
FDA Reauthorization Act of 2017
2017 · fourth_quarter · Firm: MEHLMAN CONSULTING, INC.
Issues related to drug pricing. H.R. 2430 and S. 934 - FDA User Fee Reauthorization Act. Labeling of allergens. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2430
FDA Reauthorization Act of 2017
2017 · fourth_quarter · Firm: MEHLMAN CONSULTING, INC.
Issues related to food allergies and anaphylaxis. H.R. 2430 and S. 934 - FDA User Fee Reauthorization Act. Labeling of allergens. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2430
FDA Reauthorization Act of 2017
2017 · fourth_quarter · Firm: MEHLMAN CONSULTING, INC.
Issues related to drug pricing. H.R. 2430 and S. 934 - FDA User Fee Reauthorization Act. Labeling of allergens. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations.
Client expense: — · Firm income: $30,000
Matched citations: S. 934
FDA Reauthorization Act of 2017
2017 · fourth_quarter · Firm: MEHLMAN CONSULTING, INC.
Issues related to food allergies and anaphylaxis. H.R. 2430 and S. 934 - FDA User Fee Reauthorization Act. Labeling of allergens. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations.
Client expense: — · Firm income: $30,000
Matched citations: S. 934
FDA Reauthorization Act of 2017
2017 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
Issues related to drug pricing. H.R. 2430 and S. 934 - FDA User Fee Reauthorization Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2430
FDA Reauthorization Act of 2017
2017 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
Issues related to food allergies and anaphylaxis. H.R. 2430 and S. 934 - FDA User Fee Reauthorization Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2430
FDA Reauthorization Act of 2017
2017 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
Issues related to food allergies and anaphylaxis. H.R. 2430 and S. 934 - FDA User Fee Reauthorization Act.
Client expense: — · Firm income: $30,000
Matched citations: S. 934
FDA Reauthorization Act of 2017
2017 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
Issues related to drug pricing. H.R. 2430 and S. 934 - FDA User Fee Reauthorization Act.
Client expense: — · Firm income: $30,000
Matched citations: S. 934
FDA Reauthorization Act of 2017
2017 · second_quarter · Firm: MEHLMAN CONSULTING, INC.
Issues related to food allergies and anaphylaxis. H.R. 2430 and S. 934 - FDA User Fee Reauthorization Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2430
FDA Reauthorization Act of 2017
2017 · second_quarter · Firm: MEHLMAN CONSULTING, INC.
Issues related to drug pricing. H.R. 2430 and S. 934 - FDA User Fee Reauthorization Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2430
FDA Reauthorization Act of 2017
2017 · second_quarter · Firm: MEHLMAN CONSULTING, INC.
Issues related to drug pricing. H.R. 2430 and S. 934 - FDA User Fee Reauthorization Act.
Client expense: — · Firm income: $30,000
Matched citations: S. 934
FDA Reauthorization Act of 2017
2017 · second_quarter · Firm: MEHLMAN CONSULTING, INC.
Issues related to food allergies and anaphylaxis. H.R. 2430 and S. 934 - FDA User Fee Reauthorization Act.
Client expense: — · Firm income: $30,000
Matched citations: S. 934
Source: Senate LDA